Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers.
Clinical trial NCT05060887 · COMPLETED
Trial details
- NCT number
- NCT05060887
- Sponsor
- Osivax
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2022-02-01
- Enrollment
- 239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.